Skip to Content
About Abbott
Contact
United States | eng
Country Language
CARDIOVASCULAR
United States | eng
Country Language

CLEAR

Streamlining Peripheral Artery Disease (PAD) Referral and Diagnosis to Improve Quality of Life1

CLEAR Peripheral Artery Disease Treatment Referral Program

Abbott's CLEAR Program

Developed by Abbott, based on physician and patient insights, to help patients with PAD get a timely diagnosis followed by appropriate treatment

CLEAR delivers tailor made educational resources to all involved in the PAD referral process:

  • Enhance awareness and understanding of PAD
  • Facilitate early referral of patients
  • Boost networking and collaboration between referring HCPs and vascular specialists
  • Provide easy-to-use tools to streamline referral pathway efficiency
  • Help prevent PAD progression to chronic limb-threatening ischemia (CLTI), save patients' limbs and improve quality of life1
  • Connect with an Abbott Representative to learn more on how you can get started quickly and simply.



Click below to access the CLEAR information of interest

An early referral to treatment can make a difference

Learn More
image

Help your patients understand PAD

Learn More
Understanding Peripheral Artery Disease (PAD)

Provide educational PAD tools to your patients

Learn More
Peripheral Artery Disease Patient Education Materials

An early referral to treatment can make a difference

Early diagnosis and referral are key to avoiding long-term complications.1 Collaboration between referring physicians and vascular specialists is crucial to facilitating a smooth referral process and improving patient outcomes2,3

Download Brochure
Peripheral Artery Disease (PAD) Brochure
image
image

Access further information on PAD for yourself and your patients.

Register to receive a toolkit with these materials and more

  • PAD management guidelines that provide the flow of PAD diagnosis and treatment according to current standard-of-care clinical guidelines
  • A brochure to help your patients better understand PAD
  • Patient-facing posters that highlight PAD risk factors and anatomy for your use in exam rooms
  • A PAD risk checklist for your use with patients to assess PAD risk
  • A simple guide for descriptions and instructions on how to use all the materials provided
Request Toolkit
Peripheral Artery Disease (PAD) Toolkit Request

Help your patient understand PAD

Patients diagnosed with peripheral artery disease (PAD) are likely to be concerned about their condition and will want to learn all they can about PAD and how it may affect them. PAD is a common disease affecting over 236 million people worldwide4 and presents in 15-20% of people >70 years of age.5

PAD is the presence of atherosclerotic arteries in the lower limbs, which leads to a reduction in blood flow to the extremities.6,7 PAD is associated with significant morbidity and mortality:

  • >10% of PAD patients undergo lower-extremity revascularization or amputation8
  • 5-year mortality rate of 33%9
  • 1 in 5 risk of MI, stroke, cardiovascular death, or hospitalization within one year8
  • Prevalence that increases 2-fold every 10 years10
  • Significant impact on health-related quality of life1,11

Chronic limb-threatening ischemia (CLTI) is the most severe form of PAD affecting ~2 million people in the U.S.12 and is associated with significant limb loss, pain, decreased quality of life, and mortality.13

Peripheral Artery Disease Patient Education Statistics

Patient and caregiver section

ACCESS EDUCATIONAL TOOLS FOR YOUR SUSPECTED AND DIAGNOSED PAD PATIENTS

Go to Patient & Caregiver Section

The information provided is not intended for medical diagnosis or treatment or as a substitute for professional medical advice.
Consult with a physician or qualified healthcare provider for appropriate medical advice.
This material is intended for use with healthcare professionals only.

Back to top

References:

  1. Wu A, et al. J Am Heart Assoc. 2017; 6(1): e004519.
  2. Walker CM, et al. Clin Interv Aging. 2015: 10; 1147-53.
  3. Dhand S, et al. Semin Intervent Radiol. 2018; 35: 378-83.
  4. Song P, et al. Lancet Glob Health. 2019; 7(8): e1020-30.
  5. Norgren L, et al. J Vasc Surg. 2007; 45(1): S5-67.
  6. Hirsch AT, et al. JAMA. 2001; 286(11): 1317-24.
  7. Peripheral Arterial Disease (PAD). CDC. Web. 27 Sep 2021.
  8. Steg G, et al. JAMA. 2007; 297(11): 1197-206.
  9. Tomson J, Lip GYH. BMC Cardiovasc Disord. 2005; 5: 15.
  10. Virani SS, et al. Circulation. 2021; 143(8): e254-743.
  11. Schorr EN, et al. Geriatr Nurs. 2015; 36(4): 293-300.
  12.  Duff S, et al. Vasc Health Risk Manag. 2019; 15; 187-208.
  13. Conte MS, et al. J Vasc Surg. 2019; 70(2): 662.

MAT-2208563 v2.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
abbott logo

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-1900882 v13.0